OR WAIT null SECS
Contract service providers must step up their game to stay competitive in increasingly complex bio/pharma market.
The need for preclinical testing expertise is growing as molecular complexity increases.
A look at the newest innovations offers a deeper understanding of affinity ligands and their role in the future of downstream processing.
October 01, 2008
CMOs must find new business models and strategies that reflect the many dimensions of the industry's realities...
September 25, 2008
Also, Zentiva accepts Sanofi's increased takeover bid, Oriel Therapeutics appoints Richard Fuller CEO, more...
September 18, 2008
Also, Quintiles to expand Singapore operations; Christine A. Poon, chairman of Johnson & Johnson's pharmaceuticals group, to retire; more...
September 11, 2008
Also, Human Genome Sciences enters pact with Hospira, Zosano Pharma names Gail Schulze chair and CEO, more...
September 04, 2008
Boehringer Ingelheim and and Hisoar (Taizhou, China), a pharmaceutical production company, formed a strategic production alliance in China.
Also, Novartis stops development on "Aurograb," Zealand Pharma appoints David H. Solomon as CEO, more...
September 03, 2008
CMC service providers are doing well, but clinical and preclinical CROs are doing even better.
September 02, 2008
Brief pharmaceutical news items for September 2008.
This year, the employment survey will acknowledge the industry's best employers.
FDA is taking several measures to ensure that imported drugs meet manufacturing standards.